JAK2 and acute lymphoblastic leukemia: IKZF1 alterations are more common in patients with kinase mutation as compared to patients with sequence mutation [9-14]. Approximately half of the Ph-like ALL cases have CRLF2-R with concomitant Janus kinase one/Janus kinase two (JAK1/JAK2) mutation.